Cargando…
Caplacizumab as frontline therapy in addition to standard treatment in iTTP
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196776/ https://www.ncbi.nlm.nih.gov/pubmed/36469553 http://dx.doi.org/10.1182/bloodadvances.2022009448 |
| _version_ | 1785044416771129344 |
|---|---|
| author | Cid, Joan Lozano, Miquel |
| author_facet | Cid, Joan Lozano, Miquel |
| author_sort | Cid, Joan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10196776 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101967762023-05-20 Caplacizumab as frontline therapy in addition to standard treatment in iTTP Cid, Joan Lozano, Miquel Blood Adv Commentary The American Society of Hematology 2022-12-07 /pmc/articles/PMC10196776/ /pubmed/36469553 http://dx.doi.org/10.1182/bloodadvances.2022009448 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Commentary Cid, Joan Lozano, Miquel Caplacizumab as frontline therapy in addition to standard treatment in iTTP |
| title | Caplacizumab as frontline therapy in addition to standard treatment in iTTP |
| title_full | Caplacizumab as frontline therapy in addition to standard treatment in iTTP |
| title_fullStr | Caplacizumab as frontline therapy in addition to standard treatment in iTTP |
| title_full_unstemmed | Caplacizumab as frontline therapy in addition to standard treatment in iTTP |
| title_short | Caplacizumab as frontline therapy in addition to standard treatment in iTTP |
| title_sort | caplacizumab as frontline therapy in addition to standard treatment in ittp |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196776/ https://www.ncbi.nlm.nih.gov/pubmed/36469553 http://dx.doi.org/10.1182/bloodadvances.2022009448 |
| work_keys_str_mv | AT cidjoan caplacizumabasfrontlinetherapyinadditiontostandardtreatmentinittp AT lozanomiquel caplacizumabasfrontlinetherapyinadditiontostandardtreatmentinittp |